Product image of Novetron (Ondansetron) supplied by GNH India

Novetron

Active Ingredient:
Ondansetron
Origin:
EU

Novetron (Ondansetron)

Ondansetron, the active ingredient in Novetron, is a 5‑HT3 receptor antagonist presented as an oral formulation for oral use. It is employed to prevent and treat nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative recovery in adult patients. The product conforms to European Union regulatory standards and is available by prescription.

GNH India supplies Novetron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide, ensuring reliable quality and timely delivery. Our global network supports regulatory compliance and logistics coordination for international shipments.

Manufacturer / TM Owner

Pharmagen Cz S.R.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Novetron (ondansetron) is used to control nausea and vomiting mediated by serotonin pathways in several clinical settings.
  • Chemotherapy-induced nausea and vomiting: reduces acute and delayed episodes in patients receiving emetogenic cancer therapy.
  • Radiotherapy-induced nausea and vomiting: helps control nausea associated with radiation treatment.
  • Postoperative nausea and vomiting: prevents and treats nausea and vomiting after surgical procedures.

How It Works

  • Ondansetron selectively blocks serotonin (5‑HT3) receptors located in the chemoreceptor trigger zone of the brain and on vagal afferents in the gastrointestinal tract. By inhibiting these receptors, it diminishes the stimulus for the vomiting reflex, thereby reducing nausea and vomiting triggered by chemotherapy, radiotherapy, or surgical stress.

Side Effects

Common Side Effects

  • Headache: mild to moderate pain often reported.
  • Constipation: reduced bowel movements.
  • Dizziness: transient light‑headedness.
  • Fatigue: feeling of tiredness.
  • Diarrhoea: loose stools.
  • Abdominal pain: mild discomfort.

Serious or Rare Side Effects

  • QT interval prolongation: may lead to cardiac arrhythmia.
  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Serotonin syndrome: agitation, hyperthermia when combined with other serotonergic drugs.
  • Cardiac arrhythmias: irregular heartbeat.
  • Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Precautions & Warnings

  • Before prescribing Novetron, consider the following precautions.
  • Assess cardiac risk: evaluate QT interval and correct electrolyte abnormalities.
  • Monitor electrolytes: treat hypokalaemia or hypomagnesemia before use.
  • Use with caution in hepatic impairment: dose adjustment may be required.
  • Avoid concomitant use with other QT‑prolonging agents unless benefits outweigh risks.
  • Pregnancy and lactation: discuss potential risks with the prescriber; data are limited.
  • Store at room temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Novetron may interact with other medicines; review patient medication lists.

Major Interactions (Avoid)

  • Other QT‑prolonging drugs (e.g., quinidine, haloperidol): increased risk of arrhythmia.
  • Apomorphine: may cause severe hypotension.
  • Serotonergic agents (e.g., tramadol) combined with ondansetron may raise serotonin syndrome risk.

Moderate Interactions (Monitor Closely)

  • CYP3A4 inhibitors (e.g., ketoconazole): may raise ondansetron plasma levels.
  • CYP3A4 inducers (e.g., rifampin): may reduce effectiveness.
  • Aprepitant: may require dose adjustment of ondansetron.

Frequently Asked Questions

Novetron contains ondansetron and is prescribed to prevent or treat nausea and vomiting that result from chemotherapy, radiotherapy, or surgery. It is commonly used in oncology and surgical settings to improve patient comfort and support continued treatment.

Ondansetron works by selectively blocking serotonin 5‑HT3 receptors in the brain’s chemoreceptor trigger zone and along the gastrointestinal tract. This inhibition stops the signal cascade that triggers the vomiting reflex, thereby reducing nausea.

The dose of Novetron is determined by the prescribing clinician based on the patient’s condition, treatment protocol, and other medical factors. Healthcare professionals follow established guidelines and adjust the regimen to each individual’s needs.

Safety data for ondansetron in pregnancy and lactation are limited. The prescriber should weigh potential benefits against possible risks and discuss any concerns with the patient. Breastfeeding mothers should also consult their healthcare provider before use.

To order Novetron, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Novetron (ondansetron) belongs to the 5‑HT3 antagonist class, which is generally more effective for chemotherapy‑induced nausea than dopamine antagonists such as metoclopramide. It has a different side‑effect profile, with fewer extrapyramidal symptoms but a potential for QT prolongation.

Novetron should be stored at room temperature, below 25 °C, in its original packaging. Keep it away from moisture and direct sunlight. Do not refrigerate or freeze the product unless the label specifically advises otherwise.

Novetron is taken orally, usually as a tablet or oral solution, according to the prescriber’s instructions. It can be taken with or without food, but patients should follow the specific guidance provided with their prescription.

Serious risks include QT interval prolongation, which can lead to cardiac arrhythmias, and severe allergic reactions such as anaphylaxis. Patients should be monitored for signs of irregular heartbeat, dizziness, or rash, and seek immediate medical attention if these occur.

Novetron should be avoided in patients with known hypersensitivity to ondansetron or any component of the formulation. Caution is also advised for individuals with a history of prolonged QT interval, significant electrolyte disturbances, or those taking other QT‑prolonging medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ondansetron

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT